Genomtec S.A. (GMT) — Strategic Asset Allocation Index
Genomtec S.A. (GMT) has a Strategic Asset Allocation Index of 15.1% as of June 2023. Strategic assets (PP&E of zł2.00 Million plus long-term investments of zł-) total zł2.00 Million, measured against net assets of zł13.22 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Genomtec S.A. to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Genomtec S.A. Strategic Asset Allocation Index (2020–2021)
This chart shows how Genomtec S.A.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of June 2023, the index stands at 15.1%, representing strategic assets of zł2.00 Million against net assets of zł13.22 Million PLN. For live market cap and overall valuation, see Genomtec S.A. (GMT) market capitalisation.
Annual Strategic Asset Allocation Index for Genomtec S.A. (2020–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Genomtec S.A. from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Genomtec S.A. (GMT) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (PLN) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 258.5% | zł1.91 Million | zł1.91 Million | zł- | zł738.00K | ▲ +242.2 pp |
| 2020 | 16.4% | zł1.24 Million | zł1.24 Million | zł- | zł7.57 Million | — |